MiR-5195-3p Inhibits Proliferation and Invasion of Human Bladder Cancer Cells by Directly Targeting Oncogene KLF5
Affiliations
miRNAs play a key role in the carcinogenesis of many cancers, including bladder cancer. In the current study, the role of miR-5195-3p, a quite recently discovered and poorly studied miRNA, in the proliferation and invasion of human bladder cancer cells was investigated. Our data displayed that, compared with healthy volunteers (control) and SU-HUC-1 normal human bladder epithelial cells, miR-5195-3p was sharply downregulated in bladder cancer patients and five human bladder cancer cell lines. The oligo miR-5195-3p mimic or miR-5195-3p antagomir was subsequently transfected into both T24 and BIU-87 bladder cancer cell lines. The miR-5195-3p mimic robustly increased the miR-5195-3p expression level and distinctly reduced the proliferation and invasion of T24 and BIU-87 cells. In contrast, the miR-5195-3p antagomir had an opposite effect on miR-5195-3p expression, cell proliferation, and invasion. Our data from bioinformatic and luciferase reporter gene assays identified that miR-5195-3p targeted the mRNA 3'-UTR of Krüppel-like factor 5 (KLF5), which is a proven proto-oncogene in bladder cancer. miR-5195-3p sharply reduced KLF5 expression and suppressed the expression or activation of its several downstream genes that are kinases improving cell survival or promoting cell cycle regulators, including ERK1/2, VEGFA, and cyclin D1. In conclusion, miR-5195-3p suppressed proliferation and invasion of human bladder cancer cells via suppression of KLF5.
Lv Y, Guo S, Jin L, Wang K, Li Y, Li H Cell Div. 2024; 19(1):29.
PMID: 39390599 PMC: 11468180. DOI: 10.1186/s13008-024-00133-x.
Fang Q, Xu M, Yao W, Wu R, Han R, Kawakita S Discov Oncol. 2024; 15(1):408.
PMID: 39235679 PMC: 11377401. DOI: 10.1007/s12672-024-01257-w.
MiR-5195-3p targets the PCBP2/PI3K/AKT pathway to inhibit melanoma cell proliferation and migration.
Yang B, Wu Y, Chen Y, Li Y, Wang J, Cha X Heliyon. 2023; 9(9):e19227.
PMID: 37662755 PMC: 10474410. DOI: 10.1016/j.heliyon.2023.e19227.
Wang Y, Li H, Chen W, Huang X, Fan R, Xu M Gen Thorac Cardiovasc Surg. 2023; 72(3):164-175.
PMID: 37474742 DOI: 10.1007/s11748-023-01960-5.
Yan J, Xie B, Tian Y, An W, Peng Z, Liu Z BMC Cancer. 2023; 23(1):557.
PMID: 37328795 PMC: 10273698. DOI: 10.1186/s12885-023-11068-x.